Cited by 38

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Contrasting Epidemiology of Cholera in Bangladesh and Africa

Sack, David A, Debes, Amanda K, Ateudjieu, Jerome, Bwire, Godfrey, Ali, Mohammad, Ngwa, Moise Chi, Mwaba, John, Chilengi, Roma, Orach, Christopher C, Boru, Waqo, Mohamed, Ahmed Abade, Ram, Malathi, George, Christine Marie, Stine, O Colin·2021·The Journal of Infectious Diseases

Abstract

In Bangladesh and West Bengal cholera is seasonal, transmission occurs consistently annually. By contrast, in most African countries, cholera has inconsistent seasonal patterns and long periods without obvious transmission. Transmission patterns in Africa occur during intermittent outbreaks followed by elimination of that genetic lineage. Later another outbreak may occur because of reintroduction of new or evolved lineages from adjacent areas, often by human travelers. These then subsequently undergo subsequent elimination. The frequent elimination and reintroduction has several implications when planning for cholera’s elimination including: a) reconsidering concepts of definition of elimination, b) stress on rapid detection and response to outbreaks, c) more effective use of oral cholera vaccine and WASH, d) need to readjust estimates of disease burden for Africa, e) re-examination of water as a reservoir for maintaining endemicity in Africa. This paper reviews major features of cholera’s epidemiology in African countries which appear different from the Ganges Delta.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/infdis/jiab440

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • These water-borne diseases have a high mortality rate, especially for infants and children under 5 years of age (37%).

    “These water-borne diseases have a high mortality rate, especially for infants and children under 5 years of age (37%)75–78.”

    From Impact of untreated tannery wastewater in the evolution of multidrug-resistant bacteria in Bangladesh (2024) · cites this paper as [77]

    The Abstract says severe cholera can cause death if not treated promptly, and the Ganges Delta section says young children have the highest rates of cholera. Those rates refer to cases, not deaths. The paper does not support a 37% mortality rate for children under five or extend that figure to water-borne diseases generally. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 55

  1. Ali, 2015, Updated global burden of cholera in endemic countries, PLoS Negl Trop Dis, 9, e0003832, 10.1371/journal.pntd.0003832 · DOI
  2. GBD Diarrhoeal Disease, 2018, Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016, Lancet Infect Dis, 18, 1211, 10.1016/S1473-3099(18)30362-1 · DOI
  3. 2017, Cholera vaccines: WHO position paper—August 2017, Wkly Epidemiol Rec, 92, 477
  4. International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)., 2014, Health and science bulletin: surveillance updates. Health and science bulletin, 22
  5. Sack, 2003, A 4-year study of the epidemiology of Vibrio cholerae in four rural areas of Bangladesh, J Infect Dis, 187, 96, 10.1086/345865 · DOI
  6. Azman, 2020, Vibrio cholerae O1 transmission in Bangladesh: insights from a nationally representative serosurvey, Lancet Microbe, 1, e336, 10.1016/S2666-5247(20)30141-5 · DOI
  7. Sack, 1991, Antibody responses after immunization with killed oral cholera vaccines during the 1985 vaccine field trial in Bangladesh, J Infect Dis, 164, 407, 10.1093/infdis/164.2.407 · DOI
  8. Mosley, 1968, A serological survey for cholera antibodies in rural east Pakistan. 1. The distribution of antibody in the control population of a cholera-vaccine field-trial area and the relation of antibody titre to the pattern of endemic cholera, Bull World Health Organ, 38, 327
  9. Khan, 2020, Epidemiology of cholera in Bangladesh: findings from nationwide hospital-based surveillance, 2014-2018, Clin Infect Dis, 71, 1635, 10.1093/cid/ciz1075 · DOI · Paper page
  10. Alam, 2017, Health and demographic surveillance system (HDSS) in Matlab, Bangladesh, Int J Epidemiol, 46, 809, 10.1093/ije/dyx076 · DOI
  11. Clemens, 1990, Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up, Lancet, 335, 270, 10.1016/0140-6736(90)90080-O · DOI
  12. Colwell, 2003, Reduction of cholera in Bangladeshi villages by simple filtration, Proc Natl Acad Sci U S A, 100, 1051, 10.1073/pnas.0237386100 · DOI
  13. Nair, 2010, Emerging trends in the etiology of enteric pathogens as evidenced from an active surveillance of hospitalized diarrhoeal patients in Kolkata, India, Gut Pathog, 2, 4, 10.1186/1757-4749-2-4 · DOI
  14. Qadri, 2018, Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial, Lancet Infect Dis, 18, 666, 10.1016/S1473-3099(18)30108-7 · DOI
  15. Bhattacharya, 2013, 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial, Lancet Infect Dis, 13, 1050, 10.1016/S1473-3099(13)70273-1 · DOI
  16. Mosley, 1970, Epidemiology of cholera, Public Health Pap, 40, 23
  17. Weil, 2009, Clinical outcomes in household contacts of patients with cholera in Bangladesh, Clin Infect Dis, 49, 1473, 10.1086/644779 · DOI
  18. George, 2016, Randomized controlled trial of hospital-based hygiene and water treatment intervention (CHoBI7) to reduce cholera, Emerg Infect Dis, 22, 233, 10.3201/eid2202.151175 · DOI
  19. Harris, 2008, Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh, PLoS Negl Trop Dis, 2, e221, 10.1371/journal.pntd.0000221 · DOI
  20. Huq, 2005, Critical factors influencing the occurrence of Vibrio cholerae in the environment of Bangladesh, Appl Environ Microbiol, 71, 4645, 10.1128/AEM.71.8.4645-4654.2005 · DOI
  21. Colwell, 1994, Environmental reservoir of Vibrio cholerae. The causative agent of cholera, Ann N Y Acad Sci, 740, 44, 10.1111/j.1749-6632.1994.tb19852.x · DOI
  22. Huq, 1983, Ecological relationships between Vibrio cholerae and planktonic crustacean copepods, Appl Environ Microbiol, 45, 275, 10.1128/aem.45.1.275-283.1983 · DOI
  23. George, 2017, Genetic relatedness of Vibrio cholerae isolates within and between households during outbreaks in Dhaka, Bangladesh, BMC Genomics, 18, 903, 10.1186/s12864-017-4254-9 · DOI
  24. Clemens, 1991, Biotype as determinant of natural immunising effect of cholera, Lancet, 337, 883, 10.1016/0140-6736(91)90207-6 · DOI
  25. Levine, 1981, Duration of infection-derived immunity to cholera, J Infect Dis, 143, 818, 10.1093/infdis/143.6.818 · DOI
  26. Bi, 2017, Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis, Lancet Infect Dis, 17, 1080, 10.1016/S1473-3099(17)30359-6 · DOI
  27. Van Loon, 1990, Low gastric acid as a risk factor for cholera transmission: application of a new non-invasive gastric acid field test, J Clin Epidemiol, 43, 1361, 10.1016/0895-4356(90)90103-V · DOI
  28. Sack, 1972, Gastric acidity in cholera and noncholera diarrhoea, Bull World Health Organ, 47, 31
  29. Glass, 1985, Predisposition for cholera of individuals with O blood group. Possible evolutionary significance, Am J Epidemiol, 121, 791, 10.1093/oxfordjournals.aje.a114050 · DOI
  30. Anstee, 2010, The relationship between blood groups and disease, Blood, 115, 4635, 10.1182/blood-2010-01-261859 · DOI
  31. Harris, 2005, Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity, Infect Immun, 73, 7422, 10.1128/IAI.73.11.7422-7427.2005 · DOI
  32. Levine, 1979, Genetic susceptibility to cholera, Ann Hum Biol, 6, 369, 10.1080/03014467900003751 · DOI
  33. Arifuzzaman, 2011, Individuals with Le(a+b−) blood group have increased susceptibility to symptomatic Vibrio cholerae O1 infection, PLoS Negl Trop Dis, 5, e1413, 10.1371/journal.pntd.0001413 · DOI
  34. Ngwa, 2016, Cholera in Cameroon, 2000–2012: spatial and temporal analysis at the operational (health district) and sub climate levels, PLoS Negl Trop Dis, 10, e0005105, 10.1371/journal.pntd.0005105 · DOI
  35. Debes, 2016, Clinical and environmental surveillance for Vibrio cholerae in resource constrained areas: application during a 1-year surveillance in the far north region of Cameroon, Am J Trop Med Hyg, ; 94:537–43
  36. Bwire, 2018, Environmental surveillance of Vibrio cholerae O1/O139 in the five African great lakes and other major surface water sources in Uganda, Front Microbiol, 9, 1560, 10.3389/fmicb.2018.01560 · DOI
  37. Ngwa, 2017, Cultural influences behind cholera transmission in the Far North Region, Republic of Cameroon: a field experience and implications for operational level planning of interventions, Pan Afr Med J, 28, 311, 10.11604/pamj.2017.28.311.13860 · DOI
  38. Sauvageot, 2016, Cholera incidence and mortality in sub-Saharan African sites during multi-country surveillance, PLoS Negl Trop Dis, 10, e0004679, 10.1371/journal.pntd.0004679 · DOI
  39. Bwire, 2017, Identifying cholera “hotspots” in Uganda: an analysis of cholera surveillance data from 2011 to 2016, PLoS Negl Trop Dis, 11, e0006118, 10.1371/journal.pntd.0006118 · DOI
  40. Bwire, 2020, Use of surveys to evaluate an integrated oral cholera vaccine campaign in response to a cholera outbreak in Hoima district, Uganda, BMJ Open, 10, e038464, 10.1136/bmjopen-2020-038464 · DOI
  41. Debes, 2021, Cholera hot-spots and contextual factors in Burundi, planning for elimination, Trop Med Infect Dis, 6, 76, 10.3390/tropicalmed6020076 · DOI
  42. Weill, 2017, Genomic history of the seventh pandemic of cholera in Africa, Science, 358, 785, 10.1126/science.aad5901 · DOI
  43. Bwire, 2018, Molecular characterization of Vibrio cholerae responsible for cholera epidemics in Uganda by PCR, MLVA and WGS, PLoS Negl Trop Dis, 12, e0006492, 10.1371/journal.pntd.0006492 · DOI
  44. Mwaba, 2021, Three transmission events of Vibrio cholerae O1 into Lusaka, Zambia, BMC Infect Dis, 21, 570, 10.1186/s12879-021-06259-5 · DOI
  45. Weill, 2019, Genomic insights into the 2016, Nature, 565, 230, 10.1038/s41586-018-0818-3 · DOI
  46. Bi, 2018, The epidemiology of cholera in Zanzibar: implications for the Zanzibar comprehensive cholera elimination plan, J Infect Dis, 218, 173, 10.1093/infdis/jiy500 · DOI
  47. Garg, 2003, Molecular epidemiology of O139 Vibrio cholerae: mutation, lateral gene transfer, and founder flush, Emerg Infect Dis, 9, 810, 10.3201/eid0907.020760 · DOI
  48. Ontweka, 2016, Cholera rapid test with enrichment step has diagnostic performance equivalent to culture, PLoS One, 11, e0168257, 10.1371/journal.pone.0168257 · DOI
  49. Bwire, 2017, Alkaline peptone water enrichment with a dipstick test to quickly detect and monitor cholera outbreaks, BMC Infect Dis, 17, 726, 10.1186/s12879-017-2824-8 · DOI
  50. Ngwa, 2020, The multi-sectorial emergency response to a cholera outbreak in internally displaced persons camps in Borno State, Nigeria, 2017, BMJ Glob Health, 5, e002000, 10.1136/bmjgh-2019-002000 · DOI
  51. Bwire, 2021, Refugee settlements and cholera risks in Uganda, 2016, Am J Trop Med Hyg, 104, 1225, 10.4269/ajtmh.20-0741 · DOI
  52. Garrine, 2017, Minimal genetic change in Vibrio cholerae in Mozambique over time: multilocus variable number tandem repeat analysis and whole genome sequencing, PLoS Negl Trop Dis, 11, e0005671, 10.1371/journal.pntd.0005671 · DOI
  53. Moore, 2017, El Niño and the shifting geography of cholera in Africa, Proc Natl Acad Sci U S A, 114, 4436, 10.1073/pnas.1617218114 · DOI
  54. Rebaudet, 2019, The case-area targeted rapid response strategy to control cholera in Haiti: a four-year implementation study, PLoS Negl Trop Dis, 13, e0007263, 10.1371/journal.pntd.0007263 · DOI
  55. Roskosky, 2021, Spatial clustering of cholera cases in the Kathmandu valley: implications for a ring vaccination strategy, Int Health, 13, 170, 10.1093/inthealth/ihaa042 · DOI

Cited by

Sorted by citations

Metadata

Authors
Sack, D. A., Debes, A. K., Ateudjieu, J., Bwire, G., Ali, M., Ngwa, M. C., Mwaba, J., Chilengi, R., Orach, C. C., Boru, W., Mohamed, A. A., Ram, M., George, C. M., & Stine, O. C.
Venue
The Journal of Infectious Diseases
Published
2021-09-22
Volume
224
Issue
Supplement_7
Pages
S701-S709
ISSN
  • 0022-1899
  • 1537-6613
Cited by
38
References
1
Language
en
Funders
  • Bill and Melinda Gates Foundation (OPP1148763)
  • National Institute of Allergy and Infectious Diseases (5R01AI123422)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review